• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8/12/24 4:43:57 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email
    hpco_8k.htm
    0001892480false00018924802024-08-092024-08-09iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

     

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.

    _____________________

     

    FORM 8-K

    _____________________

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): August 9, 2024

     

    Hempacco Co., Inc.

    (Exact name of registrant as specified in its charter)

     

    001-41487

     

    83-4231457

    (Commission File Number)

     

    (IRS Employer Identification Number)

     

    9925 Airway Road, San Diego, CA

     

    92154

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    (619) 779-0715

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading Symbol(s)

     

    Name of Each Exchange

    on Which Registered

    Common Stock, par value $0.001

     

    HPCO

     

    The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On August 9, 2024, the Board of Directors (the “Board”) of Hempacco Co., Inc. (the “Company”) appointed Paul Glavine and Harrison Newlands as members of the Board of the Company to fill two vacancies on the Board. Mr. Glavine and Mr. Newlands are both considered “independent” directors under relevant SEC and Nasdaq rules, and they will each serve with Jerry Halamuda on the Company’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.

     

    Paul Glavine, age 35, is the Co-founder, and has served as the Chief Growth Officer and Director, of Cybin Inc. since October 2019. With a wealth of experience and a proven track record, Mr. Glavine has been instrumental in driving the growth and innovation of several pioneering companies. Starting his impactful journey as CEO of Cybin Inc. (from October 2019 through August 2020), Mr. Glavine has led the charge in developing psychedelic therapeutics aimed at addressing critical mental health challenges. In addition to his role at Cybin, Mr. Glavine co-founded Truverra, a company dedicated to developing cannabinoid-based therapies for pain disorders. His strategic insights and leadership have propelled Truverra to the cutting edge of cannabis-based medical solutions. After this, it led him to Co-Found Harts Cannabis, a designated preroll manufacturer in Canada. As a serial entrepreneur and astute investor, Mr. Glavine has successfully raised and completed mergers and acquisitions totaling over $450 million in the past six years.

     

    Harrison Newlands, age 33, has a diverse understanding of capital markets, having invested, advised, and help co-found dozens of mid-cap companies spanning close to a decade of experience in the industry. Mr. Newlands started his career working on Bay Street as a Research Associate at MacNicol & Associates, thereafter he jumped into the fast-growing cannabis industry, and was one of the co-founders of Fire & Flower, one of Canada’s first retail-focused cannabis companies, where he led its early growth and served as Director of Business Development from March 2017-April 2019. Shortly thereafter, he helped take the first EV company public in Canada through a SPAC (Taiga Motors, where he served as strategic advisor from July 2019-March 2020), as well as launched Hoshi International, a producer of medical cannabis with a state-of-the-art facility in Portugal, focusing on the emerging European market (where he served as Director of Strategic Relations from April 2019-August 2022, and Vice President of Strategy and Investor Relations from August 2021-December 2022). Mr. Newlands then went on to co-found Hypercharge Networks, Canada’s first publicly traded EV charging company (where he was a strategic advisor from January 2021-July 2024). Mr. Newlands was formerly a partner at Rockbank Capital, a Vancouver based Merchant Bank (from July 2021-September 2023), and, since January 2018, he has been the managing partner of North King Capital, an independent Toronto-based consulting firm, where he focuses on providing advisory services to companies throughout North America, helping guide companies through the capital markets landscape. Mr. Newlands currently sits on the board of a local Ontario-based charitable foundation and mentors students and start-ups at the University of Guelph.

     

    The Company has not yet entered into any agreements with Mr. Glavine or Mr. Newlands, and the terms of their compensation have not yet been determined.

     

    Item 9.01. Financial Statements and Exhibits.

     

    The exhibits listed in the following Exhibit Index are filed as part of this report:

     

    Exhibit No.

     

    Description

     

     

     

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     
    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized.

     

     

    HEMPACCO CO., INC.

     

     

     

     

    Dated: August 12, 2024

    By:

    /s/ Sandro Piancone

     

     

    Sandro Piancone

     

     

     

    Chief Executive Officer

     

     

     
    3

     

    Get the next $HPCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hempacco Receives Notification of Deficiency from Nasdaq

      San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

      5/31/24 4:12:00 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

      NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

      5/6/24 9:30:00 AM ET
      $BNZI
      $HPCO
      $LRHC
      Computer Software: Prepackaged Software
      Technology
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

      NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

      3/28/24 9:15:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    SEC Filings

    See more
    • Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      10/10/24 5:00:29 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      9/9/24 12:45:38 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      8/23/24 4:51:27 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Titus Stuart W

      4 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:54 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

      3 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:18 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Hempacco Announces Opening of European Office as Part of International Expansion Strategy

      Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

      4/4/23 9:00:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care